Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers, Ro and LifeMD to sell Wegovy, as it looks to ...

Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...

A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.

It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...

Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...

Canada's Royal Bank of Canada will abandon its sustainable finance goals as industry practices for measuring and reporting ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...

Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.

A federal court in Texas has bolstered Novo Nordisk’s efforts to limit the production and sale of compounded versions of its GLP-1 drugs, Wegovy and Ozempic. Here are five notes: ...

Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...